| 1,299 | 2 | 18 |
| 下载次数 | 被引频次 | 阅读次数 |
新型冠状病毒爆发初期,对其认识不足,随着基础和临床不断地深入研究,病毒的基本性状和临床感染特征逐渐被人们认识。本文通过近期文献报道对新型冠状病毒肺炎的流行病学和临床诊疗方面作初步综述,以期能够为广大临床医生和科研工作者在与新型冠状病毒斗争中提供帮助。
Abstract：At the beginning of the outbreak of the virus, there was limited information about it. With the in-depth study in the basic and clinical, the characteristics and clinical infection symptoms of the virus are gradually recognized. This article provides a preliminary review of the epidemiology and clinical diagnosis and treatment of the new coronavirus pneumonia through recent literature reports, with a view to providing help for clinicians and researchers in the fight against new coronavirus.
1 Wu F,Zhao S,Yu B,et al.A new coronavirus associated with human respiratory disease in China[J].Nature,2020,579(7798):265-269.
2 World Health Organizaiton.Statement on the second meeting of the International Health Regulations (2005)Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)[EB/OL].[2020-01-31].https://www.who.int/news-room/detail/23-01-2020-statement-on-the-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov).
3 Lu R,Zhao X,Li J,et al.Genomiccharacterisation and epidemiology of 2019 novel coronavirus:implications for virus origins and receptor binding[J].The Lancet,2020,395(10224):565-574.
4 Zhou P,Yang XL,Wang XG,et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin[J].Nature,2020,579(7798):270-273.
5 Ji W,Wang W,Zhao X,et al.Cross-species transmission of the newly identified coronavirus 2019-nCoV[J].J Med Virol,2020,92(4):433-440.
6 Guo Q,Li M,Wang C,et al.Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm[J].2020,DOI:10.1101/2020.01.21.914044.
7 Liu Z,Xiao X,Wei X,et al.Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2[J].J Med Virol,2020,(92):595-601.
8 Xiao K,Zhai J,Feng Y,et al.Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins[J].Nature,2020,583:286–289.
9 Zhang T,Wu Q,Zhang Z.Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak[J].CurrBiol,2020,30(7):1346-1351.e2.
10 Chen N,Zhou M,Dong X,et al.Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan,China:a descriptive study[J].The Lancet,2020,395(10223):507-513.
11 Wang D,Hu B,Hu C,et al.Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan,China[J].JAMA,2020,323(11):1061-1069.
12 Huang C,Wang Y,Li X,et al.Clinical features of patients infected with 2019 novel coronavirus in Wuhan,China[J].The Lancet,2020,395(10223):497-506.
13 Li Q,Guan X,Wu P,et al.Early Transmission Dynamics in Wuhan,China,of Novel Coronavirus–Infected Pneumonia[J].2020,382(13):1199-1207.
14 Guan WJ,Ni ZY,Hu Y,et al.Clinical characteristics of coronavirus disease 2019 in China[J].2020,382(18):1708-1720.
15 中国疾病预防控制中心新型冠状病毒肺炎应急响应机制流行病学组.新型冠状病毒肺炎流行病学特征分析[J].中华流行病学杂志,2020,41(2):145-151.
16 Badawi A,Ryoo SG.Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV):A systematic review and meta-analysis[J].Int J Infect Dis,2016,49:129-133.
17 Channappanavar R,Fett C,Mack M,et al.Sex-based differences in susceptibility to severe acuterespiratory syndrome coronavirus infection[J].Immunol,2017,198:4046-4053.
18 Jaillon S,Berthenet K,Garlanda C.Sexual dimorphism in innate immunity[J].Clin Rev Allergy Immunol,2019,56:308-321.
19 国家卫生健康委办公厅.新型冠状病毒肺炎诊疗方案(试行第七版)[J].传染病信息,2020,33(1):1-6,26.
20 Wan Y,Shang J,Graham R,et al.Receptor recognition by the novel coronavirus from Wuhan:An analysis based on decade-long structural studies of SARS coronavirus[J].2020,94(7):e00127-00120.
21 Xu X,Chen P,Wang J,et al.Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission[J].Sci China Life Sci,2020,63(3):457-460.
22 Mao L,Jin H,Wang M,et al.Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan,China[J].JAMA Neurol,2020,77(6):1-9.
23 Holshue ML,Debolt C,Lindquist S,et al.First case of 2019 novel coronavirus in the United States[J].2020,382(10):929-936.
24 胡喆,钟南山、李兰娟院士团队从新冠肺炎患者粪便中分离出病毒[J].新华社“新华视点”微博,2020.
25 方晴,钟南山团队:从患者尿液中分离出新冠状病毒[N].广州日报,2020.
26 Zhou Y,Zeng Y,Tong Y,et al.Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva[J].Med Rxiv,2020,DOI:10.1101/2020.02.11.20021956.
27 Xia J,Tong J,Liu M,et al.Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection[J].J Med Virol,2020,DOI:10.1002/jmv.25725.
28 Rothe C,Schunk M,Sothmann P,et al.Transmission of 2019-nCoV infection from an asymptomatic contact in Germany[J].New England Journal of Medicine,2020,382(10):970-971.
29 Riou J,Althaus CL.Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV),December 2019 to January 2020[J].Euro Surveill,2020,DOI:10.1101/2020.01.23.917351.
30 Davies A,Jones D,Bailey M,et al.Extracorporeal membrane oxygenation for 2009 Influenza A(H1N1) acute respiratory distress syndrome[J].JAMA,2009,302:1888-1895.
31 Arabi YM,Al-Omari A,Mandourah Y,et al.Critically ill patients with the Middle East respiratory syndrome:a multicenter retrospective cohort study[J].Crit Care Med,2017,45:1683-1695.
32 张华东,潘楚云,江意春,等.体外膜肺抢救危重症合并严重心肺功能衰竭的Meta分析[J].临床急诊杂志,2020,21(4):292-295.
33 Dominic Lee,Wing YK,Henry Leung,et al.Factors associated with psychosis among patients with severe acute respiratory syndrome:A Case-Control Study[J].Clinical Infectious Diseases,2004,39:1247-1249.
34 贾卫东,邓西龙,唐小平,等.SARS治疗中糖皮质激素应用剂量的探讨[J].南方医科大学学报,2009,29(11):2284.
35 Sheahan TP,Sims AC,Graham RL,et al.Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses[J].Science Translational Medicine,2017,9(396):eaal3653.
36 Clinical Trials.gov.[EB/OL].https://clinicaltrials.gov.
37 Wang Y,Zhang D,DU G,et al.Remdesivir in adults with severe COVID-19:A randomised,double-blind,placebo-controlled,multicentretrial[J].The Lancet,2020,395(10236):P1569-1578.
38 National Institutes of Health.[EB/OL].https://www.nih.gov/news-events/news-releases/nih-clinical-trial-testing-antiviral-remdesivir-plus-anti-inflammatory-drug-baricitinib-covid-19-begins.
39 Thanh LT,Andreadakis Z,Kumar A,et al.The COVID-19 vaccine development landscape[J].Nat Rev Drug Discov,2020,19(5):305-306.
基本信息:
DOI：10.13210/j.cnki.jhmu.20200629.001
中图分类号:R563.1
引用信息:
[1]韩雨旋,夏乾峰.新型冠状病毒的基础和临床研究进展[J].海南医学院学报,2020,26(14):1051-1055+1062.DOI:10.13210/j.cnki.jhmu.20200629.001.
2020-06-30
2020-06-30
2020-06-30